Print pageEmail pageRSS Feeds

We are building a strong, well-run business, structured to deliver sustainable results over the long term.

Along with biotechnology leadership, the ARIAD team is focused on its commitment to deliver long-term value to investors through solid business execution. That means maintaining disciplined cost control, thoughtful capital deployment and the highest standards of corporate governance.

Webcast ImageWebcast - Replay
ARIAD Pharmaceuticals, Inc. at Bank of America Merrill Lynch Health Care Conference
05/14/13 at 10:00 a.m. PT
ARIAD Pharmaceuticals, Inc. at Bank of America Merrill Lynch Health Care Conference
Tuesday, May 14, 2013 10:00 a.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast - Replay
Q1 2013 ARIAD Pharmaceuticals, Inc. Earnings Conference Call
05/07/13 at 8:30 a.m. ET
Q1 2013 ARIAD Pharmaceuticals, Inc. Earnings Conference Call
Tuesday, May 7, 2013 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Recent Press Releases
05/15/13
ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2013 ASCO Annual Meeting
05/13/13
ARIAD to Present at UBS Global Healthcare Conference
More >>
Investor Downloads
Download Documentation AP26113 in ALK and ROS1 - AACR 2013
Download Documentation Ponatinib activity against KIT – AACR 2013
Download Documentation Ponatinib activity in FGFR – AACR 2013
More >>

ARIAD Stock Price: $16.67

Stock Symbol: ARIA

Stock Exchange: NASDAQ

Stock Quote at: 05/17/13

4:00 p.m. ET
(US Dollar)
CHANGE (%) Stock is Up 0.20 (1.21%)
VOL3,261,521
OPEN$16.66
PREV. CLOSE$16.47
DAY HIGH$16.85
DAY LOW$16.40
52 WK. HIGH$25.40
Minimum 20 minute delay
Refresh quote
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue